Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Alcoholism × Lymphoid × Clear all

Status

Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma 331 Lymphoma, Non-Hodgkin 308 Leukemia, Lymphocytic, Chronic, B-Cell 286 Precursor Cell Lymphoblastic Leukemia-Lymphoma 262 Lymphoma, Large B-Cell, Diffuse 213 Lymphoma, Follicular 210 Leukemia 181 Hodgkin Disease 148 Lymphoma, Mantle-Cell 145 Leukemia, Myeloid, Acute 144 Multiple Myeloma 120 Myelodysplastic Syndromes 118 Recurrence 111 Burkitt Lymphoma 111 Lymphoma, B-Cell, Marginal Zone 108 Lymphoma, T-Cell, Cutaneous 82 Mycosis Fungoides 74 Neoplasms 70 Lymphoma, B-Cell 69 Waldenstrom Macroglobulinemia 66 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 64 Sezary Syndrome 63 Lymphoma, Large-Cell, Immunoblastic 60 Neoplasms, Plasma Cell 50 Myeloproliferative Disorders 50 Lymphoma, Large-Cell, Anaplastic 48 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 47 Primary Myelofibrosis 43 Blast Crisis 41 Hematologic Neoplasms 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03876132 2020-07-29

DEPREV

University Hospital, Brest

Alcoholism, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡